Published in Blood on March 27, 2003
Polyphosphate enhances fibrin clot structure. Blood (2008) 1.89
Gamma' fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease. Clin Chem (2010) 1.80
Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains. Blood (2005) 1.64
Mechanisms of fibrin polymerization and clinical implications. Blood (2013) 1.42
Molecular mechanisms affecting fibrin structure and stability. Arterioscler Thromb Vasc Biol (2011) 1.27
The presence of gamma' chain impairs fibrin polymerization. Thromb Res (2009) 1.06
Structural insights into fibrinogen dynamics using amide hydrogen/deuterium exchange mass spectrometry. Biochemistry (2013) 1.04
The chymotrypsin-like protease complex of Treponema denticola ATCC 35405 mediates fibrinogen adherence and degradation. Infect Immun (2007) 1.02
Assessment of genetic determinants of the association of γ' fibrinogen in relation to cardiovascular disease. Arterioscler Thromb Vasc Biol (2011) 0.93
Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1. J Transl Med (2011) 0.92
Association between γ' fibrinogen levels and inflammation. Thromb Haemost (2010) 0.91
The fibrinogen γA/γ' isoform does not promote acute arterial thrombosis in mice. J Thromb Haemost (2014) 0.88
Molecular mechanisms, thermodynamics, and dissociation kinetics of knob-hole interactions in fibrin. J Biol Chem (2013) 0.87
Fibrinolysis and the control of blood coagulation. Blood Rev (2014) 0.86
Fibrinogen-elongated gamma chain inhibits thrombin-induced platelet response, hindering the interaction with different receptors. J Biol Chem (2008) 0.85
Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin. J Biol Chem (2013) 0.84
Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol (2015) 0.82
Specific effects of fibrinogen and the γA and γ'-chain fibrinogen variants on angiogenesis and wound healing. Tissue Eng Part A (2014) 0.76
Primed to Understand Fibrinogen in Cardiovascular Disease. Arterioscler Thromb Vasc Biol (2016) 0.75
Fibrinogen and Fibrin in Hemostasis and Thrombosis. Arterioscler Thromb Vasc Biol (2017) 0.75
Fibrinogen-Related Proteins in Tissue Repair: How a Unique Domain with a Common Structure Controls Diverse Aspects of Wound Healing. Adv Wound Care (New Rochelle) (2015) 0.75
Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin. J Biol Chem (2014) 0.75
Liposomes bearing fibrinogen could potentially interfere with platelet interaction and procoagulant activity. Int J Nanomedicine (2012) 0.75
Prospective study of γ' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE). Thromb Res (2016) 0.75
Carbohydrate-binding activities of coagulation factors fibrinogen and fibrin. Glycoconj J (2015) 0.75
In vivo study of novelly formulated porcine-derived fibrinogen as an efficient sealant. J Mater Sci Mater Med (2015) 0.75
Fibrin Formation, Structure and Properties. Subcell Biochem (2017) 0.75
Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol (2011) 1.59
Interactions between factor XIII and the alphaC region of fibrinogen. Blood (2011) 1.58
Altered fibrin clot structure and function in the healthy first-degree relatives of subjects with intermittent claudication. J Vasc Surg (2008) 1.43
The activation peptide cleft exposed by thrombin cleavage of FXIII-A(2) contains a recognition site for the fibrinogen α chain. Blood (2013) 1.42
Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness. Blood (2007) 1.25
The pleiotropic role of the fibrinogen gamma' chain in hemostasis. Blood (2009) 1.25
Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin. Blood (2010) 1.23
Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function. Circulation (2003) 1.17
Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease. Arterioscler Thromb Vasc Biol (2004) 1.17
Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood (2011) 1.15
Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation (2002) 1.13
Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. Lancet (2003) 1.10
Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes. ACS Nano (2010) 1.06
Markers of inflammation in men with small abdominal aortic aneurysm. J Vasc Surg (2010) 1.01
A variant in LDLR is associated with abdominal aortic aneurysm. Circ Cardiovasc Genet (2013) 1.00
The molecular physiology and pathology of fibrin structure/function. Blood Rev (2005) 1.00
Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibrinolysis and clot rigidity. Blood (2007) 0.99
Substrates of Factor XIII-A: roles in thrombosis and wound healing. Clin Sci (Lond) (2013) 0.96
Fibrin clot structure in patients with end-stage renal disease. Thromb Haemost (2007) 0.95
α-α Cross-links increase fibrin fiber elasticity and stiffness. Biophys J (2012) 0.93
Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis. Br J Haematol (2002) 0.93
Complement C3 is a novel plasma clot component with anti-fibrinolytic properties. Diab Vasc Dis Res (2012) 0.90
Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: implications for subcellular trafficking and secretion. Blood (2010) 0.90
The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation. Diabetes (2002) 0.86
Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol (2002) 0.86
Role of fibrin structure in thrombosis and vascular disease. Adv Protein Chem Struct Biol (2011) 0.85
Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction. Blood (2002) 0.84
Plasma thrombin-antithrombin complex, prothrombin fragments 1 and 2, and D-dimer levels are elevated after endovascular but not open repair of infrarenal abdominal aortic aneurysm. J Vasc Surg (2013) 0.83
Nanoscale probing reveals that reduced stiffness of clots from fibrinogen lacking 42 N-terminal Bbeta-chain residues is due to the formation of abnormal oligomers. Biophys J (2009) 0.83
Alteration of fibrin clot properties by ultrafine particulate matter. Thromb Haemost (2009) 0.82
Clot architecture is altered in abdominal aortic aneurysms and correlates with aneurysm size. Arterioscler Thromb Vasc Biol (2011) 0.82
Elevated properdin and enhanced complement activation in first-degree relatives of South Asian subjects with type 2 diabetes. Diabetes Care (2012) 0.82
The relation between insulin resistance and hemostasis: pleiotropic genes and common environment. Twin Res (2003) 0.81
Fibrinogen and fibrin clot structure in diabetes. Herz (2004) 0.80
Evidence that fibrinogen γ' regulates plasma clot structure and lysis and relationship to cardiovascular risk factors in black Africans. Blood (2013) 0.79
Joint linkage and association of six single-nucleotide polymorphisms in the factor XIII-A subunit gene point to V34L as the main functional locus. Arterioscler Thromb Vasc Biol (2006) 0.79
Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity. Blood (2013) 0.79
Factor XIII A-subunit concentration predicts outcome in stroke subjects and vascular outcome in healthy, middle-aged men. Br J Haematol (2002) 0.78
Regarding "Altered fibrin clot structure and function in individuals with intermittent claudication". J Vasc Surg (2009) 0.77
Complement C3 is a substrate for activated factor XIII that is cross-linked to fibrin during clot formation. Br J Haematol (2012) 0.75
BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes. Thromb Haemost (2016) 0.75
Role of proteomic technologies in understanding risk of arterial thrombosis. Expert Rev Proteomics (2009) 0.75
Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction. Blood (2011) 0.75